about
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidat...
Read More
25.50
0.29
(1.15%)
33,763
XNAS Volume
XNAS 16 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Surrozen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..